XML 51 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1

Revenue from contracts with customers (Tables)

12 Months Ended

Dec. 31, 2021

Summary of disaggregates revenues by major revenue streams

The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 19.

		Year ended December 31, 2021
		North America				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			6,394				4,807				1,889				739				13,829
Licensing arrangements			92				50				13				4				160
Distribution			1,323				1				65				—				1,390
Other			(1	)			27				65				408				500
		$	7,809			$	4,886			$	2,032			$	1,151			$	15,878

		Year ended December 31, 2020
		North America				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			6,902				4,736				1,946				772				14,354
Licensing arrangements			84				32				9				4				129
Distribution			1,462				3				30				—				1,495
Other			§				(14	)			169				527				680
		$	8,447			$	4,757			$	2,154			$	1,302			$	16,659

		Year ended December 31, 2019
		North America				Europe				International Markets				Other activities				Total
		(U.S.$ in millions)
Sale of goods			6,941				4,770				2,045				754				14,510
Licensing arrangements			109				29				4				5				147
Distribution			1,492				2				20				—				1,514
Other			§				(6	)			177				545				716
		$	8,542			$	4,795			$	2,246			$	1,304			$	16,887

§ Represents an amount less than $1 million.

Summary of Sales Reserves and Allowances

The changes in SR&A for third-party sales for the period ended December 31, 2021 and 2020 were as follows:

		Sales Reserves and Allowances
		Reserves included in Accounts Receivable, net				Rebates				Medicaid and other governmental allowances				Chargebacks				Returns				Other				Total reserves included in Sales Reserves and Allowances				Total
		(U.S.$ in millions)
Balance at January 1, 2020		$	87				2,895			$	1,109			$	1,342			$	637			$	176			$	6,159			$	6,246
Provisions related to sales made in current year period			391				4,703				744				8,438				459				71				14,415			$	14,806
Provisions related to sales made in prior periods			—				(219	)			(184	)			(65	)			(28	)			(1	)			(497	)		$	(497	)
Credits and payments			(398	)			(5,360	)			(849	)			(8,614	)			(386	)			(100	)			(15,309	)		$	(15,707	)
Translation differences			—				35				8				7				4				2				56			$	56
Balance at December 31, 2020		$	80				2,054			$	828			$	1,108			$	686			$	148			$	4,824			$	4,904
Provisions related to sales made in current year period			382				4,030				852				7,967				263				314				13,426			$	13,808
Provisions related to sales made in prior periods			(9	)			(125	)			(51	)			(47	)			(60	)			(26	)			(309	)		$	(318	)
Credits and payments			(385	)			(4,275	)			(768	)			(7,937	)			(350	)			(321	)			(13,651	)		$	(14,036	)
Translation differences			—				(29	)			(7	)			(6	)			(4	)			(3	)			(49	)		$	(49	)
Balance at December 31, 2021		$	68				1,655				854				1,085				535				112				4,241			$	4,309

X

- Definition

Tabular disclosure of sales reserves and allowances current.

+ References

No definition available.

+ Details

Name:	teva_SalesReservesAndAllowancesCurrentTableTextBlock
Namespace Prefix:	teva_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration